FNY Investment Advisers’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36K Sell
350
-10,871
-97% -$638K 0.01% 462
2026
Q1
$428K Buy
+11,221
New +$355K 0.19% 116
2025
Q4
Sell
-1,500
Closed -$32K 939
2025
Q3
$32K Sell
1,500
-400
-21% -$8.97K 0.01% 597
2025
Q2
$48K Buy
+1,900
New +$55.6K 0.02% 407
2024
Q2
Sell
-1,000
Closed -$33 451
2024
Q1
$33 Buy
+1,000
New +$33.6K 0.02% 308
2022
Q2
Sell
-2,200
Closed -$107K 701
2022
Q1
$127K Buy
+2,200
New +$120K 0.12% 151
2020
Q3
Sell
-2,000
Closed -$90K 482
2020
Q2
$90K Hold
2,000
0.05% 176
2020
Q1
$91K Sell
2,000
-4,500
-69% -$204K 0.07% 181
2019
Q4
$280K Buy
6,500
+2,500
+63% +$102K 0.09% 181
2019
Q3
$144K Buy
4,000
+2,500
+167% +$105K 0.04% 241
2019
Q2
$70K Sell
1,500
-500
-25% -$21.1K 0.02% 326
2019
Q1
$70K Sell
2,000
-2,500
-56% -$98.3K 0.02% 291
2018
Q4
$168K Buy
4,500
+2,700
+150% +$105K 0.06% 139
2018
Q3
$61K Hold
1,800
0.01% 343
2018
Q2
$44K Buy
+1,800
New +$50.1K 0.02% 293

Other funds holding ATEX

FNY Investment Advisers's ATEX Position: Q2 2026 in Review

FNY Investment Advisers reduced its Anterix (ATEX) stake by 97% in Q2 2026, selling an estimated $638K and leaving 350 shares worth $36K. The position accounts for 0.01% of the portfolio, ranked #462.

FNY Investment Advisers first reported a position in ATEX in Q2 2018 and has held it in 15 quarters since. The position peaked at $428K in Q1 2026. 30 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • FNY Investment Advisers held 350 shares of Anterix worth $36K as of Q2 2026.
  • FNY Investment Advisers sold 10,871 Anterix shares in Q2 2026, an estimated $638K.
  • Anterix made up 0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #462 holding.
  • FNY Investment Advisers first reported a position in Anterix in Q2 2018 and has held it in 15 quarters since.
  • FNY Investment Advisers's Anterix position peaked at $428K in Q1 2026.
  • 30 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.